HilleVax (HLVX) Stock Forecast, Price Target & Predictions
HLVX Stock Forecast
HilleVax stock forecast is as follows: an average price target of $32.00 (represents a 1658.24% upside from HLVX’s last price of $1.82) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.
HLVX Price Target
HLVX Analyst Ratings
Hold
HilleVax Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Mar 21, 2024 | Stephen Willey | Stifel Nicolaus | $34.00 | $15.87 | 114.24% | 1768.13% |
May 25, 2022 | David Risinger | Leerink Partners | $30.00 | $10.11 | 196.74% | 1548.35% |
10
HilleVax Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $34.00 |
Last Closing Price | $1.82 | $1.82 | $1.82 |
Upside/Downside | -100.00% | -100.00% | 1768.13% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 09, 2024 | H.C. Wainwright | - | Neutral | Downgrade |
Jul 08, 2024 | Guggenheim | Buy | Neutral | Downgrade |
May 25, 2022 | SVB Leerink | - | Outperform | Initialise |
May 24, 2022 | Guggenheim | - | Buy | Initialise |
10
HilleVax Financial Forecast
HilleVax Revenue Forecast
Quarter
Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|
Revenue | - | - | - | - |
Avg Forecast | - | - | - | - |
High Forecast | - | - | - | - |
Low Forecast | - | - | - | - |
# Analysts | - | - | - | - |
Surprise % | - | - | - | - |
Forecast
HilleVax EBITDA Forecast
Quarter
Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|
# Analysts | - | - | - | - |
EBITDA | - | - | - | - |
Avg Forecast | - | - | - | - |
High Forecast | - | - | - | - |
Low Forecast | - | - | - | - |
Surprise % | - | - | - | - |
Forecast
HilleVax Net Income Forecast
Quarter
Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|
# Analysts | - | - | - | - |
Net Income | - | - | - | - |
Avg Forecast | $-26.67M | $-18.64M | $-20.59M | $-38.43M |
High Forecast | $-26.67M | $-15.21M | $-20.59M | $-38.43M |
Low Forecast | $-26.67M | $-26.00M | $-20.59M | $-38.43M |
Surprise % | - | - | - | - |
Forecast
HilleVax SG&A Forecast
Quarter
Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|
# Analysts | - | - | - | - |
SG&A | - | - | - | - |
Avg Forecast | - | - | - | - |
High Forecast | - | - | - | - |
Low Forecast | - | - | - | - |
Surprise % | - | - | - | - |
Forecast
HilleVax EPS Forecast
Quarter
Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|
# Analysts | - | - | - | - |
EPS | - | - | - | - |
Avg Forecast | $-0.54 | $-0.38 | $-0.42 | $-0.78 |
High Forecast | $-0.54 | $-0.31 | $-0.42 | $-0.78 |
Low Forecast | $-0.54 | $-0.53 | $-0.42 | $-0.78 |
Surprise % | - | - | - | - |
Forecast
HilleVax Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
HLVX | HilleVax | $1.82 | $32.00 | 1658.24% | Hold |
IPSC | Century Therapeutics | $1.24 | $15.00 | 1109.68% | Buy |
STTK | Shattuck Labs | $1.01 | $12.00 | 1088.12% | Hold |
PMVP | PMV Pharmaceuticals | $1.61 | $18.00 | 1018.01% | Buy |
PEPG | PepGen | $4.32 | $29.50 | 582.87% | Buy |
MOLN | Molecular Partners | $5.42 | $29.00 | 435.06% | Buy |
OPT | Opthea | $3.13 | $14.00 | 347.28% | Buy |
STRO | Sutro Biopharma | $2.53 | $11.14 | 340.32% | Buy |
VIGL | Vigil Neuroscience | $3.00 | $11.00 | 266.67% | Buy |
CCCC | C4 Therapeutics | $4.01 | $13.50 | 236.66% | Buy |
CGEM | Cullinan Oncology | $12.22 | $31.50 | 157.77% | Buy |
ELYM | Eliem Therapeutics | $5.11 | $13.00 | 154.40% | Buy |
MLYS | Mineralys Therapeutics | $11.87 | $30.00 | 152.74% | Buy |
PHVS | Pharvaris | $21.04 | $39.67 | 88.55% | Buy |
EWTX | Edgewise Therapeutics | $31.98 | $45.00 | 40.71% | Buy |
CNTA | Centessa Pharmaceuticals | $18.19 | $23.25 | 27.82% | Buy |
TRDA | Entrada Therapeutics | $18.05 | $20.00 | 10.80% | Buy |